Uncontrolled study of post-exposure prophylaxis for influenza by peramivir

Uncontrolled study of post-exposure prophylaxis for influenza by peramivir - Post-exposure prophylaxis for influenza by peramivir

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014519

Enrollment

Registered

2014-10-01

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients exposed to influenza

Interventions

A single dose of Peramivir 300mg is intravenously injected.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who contacted with other influenza patients. (2) Patients who cannot take oseltamivir orally or inhale zanamivir. (3) Patients who need prevention of influenza virus infection. (4) Patients who were explained with this study and accept to receive Permivir.

Exclusion criteria

Exclusion criteria: Patients who were judged to be inadequate for this study.

Design outcomes

Primary

Measure	Time frame
Secondary infection of patients received peramivir after influenza exposure.	—

Countries

Japan

Contacts

Public ContactNobuhisa Ishiguro

Hokkaido University Hospital Infection Control Team

nishigur@med.hokudai.ac.jp011-706-5703

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026